ALTORAN 40MG 10

About

ALTORAN 40MG, containing Telmisartan 40mg, is an angiotensin II receptor blocker (ARB) primarily used for the management of essential hypertension. It works by selectively blocking the AT1 receptor, which is responsible for the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This blockade leads to a reduction in systemic vascular resistance and a subsequent decrease in blood pressure. Telmisartan is known for its long duration of action, allowing for effective 24-hour blood pressure control with once-daily dosing.

Beyond its antihypertensive properties, Telmisartan has demonstrated efficacy in reducing the risk of cardiovascular events, including myocardial infarction and stroke, in high-risk patients. It is a valuable option for individuals who cannot tolerate ACE inhibitors due to side effects like persistent cough. Close monitoring of blood pressure, electrolytes, and renal function is recommended throughout the course of treatment to ensure optimal safety and efficacy.

Uses

• Treatment of essential hypertension.
• Reduction of cardiovascular risk in high-risk individuals.
• Prevention of stroke and myocardial infarction.
• Alternative for patients intolerant to ACE inhibitors.

Directions For Use

Take one tablet orally once daily, with or without food, as directed by your healthcare provider. Swallow the tablet whole with water.

Benefits

• Effective in lowering high blood pressure.
• Reduces the risk of major cardiovascular events.
• Provides sustained 24-hour blood pressure control.
• Lower incidence of cough compared to ACE inhibitors.
• Generally well-tolerated.
• Suitable for long-term management of hypertension.

Side Effects

• Dizziness.
• Hypotension.
• Fatigue.
• Back pain.
• Diarrhea.
• Nausea.
• Hyperkalemia.
• Renal dysfunction.
• Upper respiratory tract infection.
• Cough.
• Muscle cramps.
• Angioedema.

Safety Measures

• Alcohol - Alcohol can enhance the hypotensive effect; use with caution and limit intake.
• Pregnancy - Contraindicated during the second and third trimesters due to significant risk of fetal harm and death.
• Breastfeeding - Not recommended; consider alternative treatments or discontinue breastfeeding.
• Liver - Use with caution in patients with severe hepatic impairment; lower doses may be required.
• Kidney - Monitor renal function, especially in patients with pre-existing renal impairment or renal artery stenosis.
• Lung - Generally safe for patients with lung conditions as it does not directly affect respiratory function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.